|

MOMA-313 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • MOMA Therapeutics1

Indications

  • Homologous Recombination Deficiency1
  • Metastatic Solid Tumor1
  • Pancreas Cancer1
  • Advanced Solid Tumor1
  • Ovarian Cancer1

Goodyear, Arizona1 trial

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #108

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.